-
Part 3 | Session 2 "Ultrasound RDN - Reviewing the Latest Clinical Results" : Joost Daemen
-
Part 3 | Session 3 "How to build Interventional HTN Therapy/Practice": Joachim Weil
-
Part 4 | Session 1 RADIANCE II Pivotal Trial
-
Part 5 | Session 3 ACC 2021 – RADIANCE-HTN TRIO Trial Results with Ajay Kirtane
-
Part 5 | Session 4 EuroPCR 2020 – Crossover Results From the RADIANCE-HTN SOLO Trial
-
Part 7 | Session 1 ACC 2022 Symposium
-
Part 7 | Session 2 TCT 2021 Symposium
-
Part 1 | Session 1 The Science of Ultrasound Renal Denervation: Introduction
-
Part 1 | Session 2 Ultrasound Technology – Its Development and Unique Characteristics: Andy Wu
-
Part 1 | Session 3 Ultrasound Renal Denervation Preclinical Evidence: Dr Michael Joner
-
Part 1 | Session 4 RDN Procedure with Ultrasound Technology: Prof Felix Mahfoud
-
Part 1 | Session 5 Panel Discussion: All
-
Part 2 | Session 1 The Paradise uRDN System: Dr Andrew Sharp
Ultrasound Renal Denervation (uRDN) is an innovative therapy option for the treatment of uncontrolled hypertension. uRDN therapy is delivered in a minimally invasive procedure that may lower high blood pressure by treating overactive renal nerves with ultrasound energy.
This page provides an overview of uRDN technology and the latest evidence from its associated RADIANCE clinical program.
The PARADISETM System is Limited to Investigational Use Only in the United States. Approved for distribution in CE mark countries only.
What you will learn:
- How uRDN works and its potential benefits for patients suffering from uncontrolled hypertension
- The clinical evidence supporting uRDN and its implications for the field of hypertension
- The process for building a uRDN centre and therapy network
This page is designed for:
- Interventional cardiologists
- General cardiologists
- Hypertension specialists
- Nephrologists
- Interventional radiologists
More from this programme
Part 1
The Science of uRDN
Part 2
The Evidence for uRDN
Part 3
From Proof to Practice – Treating Hypertension With uRDN
Part 4
RADIANCE II Pivotal Trial for Paradise Ultrasound Renal Denervation System in Patients With Hypertension
Part 5
Results From the Latest Clinical Trials
Part 6
Patient Perspective & Provider Referral Development
Part 7
Discussion With Experts
| 2 sessions | |
| ACC 2022 Symposium | Watch now |
| TCT 2021 Symposium | Watch now |
Faculty Biographies
Roland E Schmieder
Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension
Roland E Schmieder is a German physician-scientist whose career has been dedicated to internal medicine, nephrology, and hypertension. He has spent the majority of his professional life in Germany, where he has combined patient care, clinical research, and academic leadership at major university and community hospitals. His work has focused on the prevention and treatment of cardiovascular and renal disease, with an emphasis on hypertension and vascular risk.
Academic History
Professor Schmieder graduated in medicine from the University of Tübingen, Germany. He completed his post-graduate medical training in nephrology, cardiology, and hypertension at the University Hospital of Bonn. He later pursued advanced training at the Alton Ochsner Foundation in New Orleans, United States, where he further expanded his expertise in cardiovascular and renal medicine and clinical research.
Career Overview
Professor Schmieder is Professor of…